MARK CHIN

Profile

First Name

: MARK

Middle Name

:

Last Name

: CHIN

Related Companies
Titles
Company Name
Related People
DIRECTOR
OPTIKIRA, LLC
BRADLEY BACKES, DUSTIN MALY, SCOTT OAKES, FEROZ PAPA, BAIJU SHAH, THEODORE TORPHY
DIRECTOR
ITERUM THERAPEUTICS LTD
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, MICHAEL W. DUNNE, PAUL R. EDICK, COREY N. FISHMAN, JAMES I. HEALY, PATRICK HERON, PATRICK J. HERON, ROBERT HOPFNER, RONALD M. HUNT, DAVID KELLY, DAVID I. KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS, TRACY SAXTON, JEFF SCHAFFNIT
DIRECTOR
HARPOON THERAPEUTICS, INC.
PATRICK BAEUERLE, JOSEPH BAILES, PABLO CAGNONI, ALAN COLOWICK, JONATHAN DRACHMAN, JULIE EASTLAND, GEORGIA L. ERBEZ, LUKE EVNIN, DAN HICKLIN, RON HUNT, RONALD HUNT, GERALD MCMAHON, SCOTT MYERS, WILLIAM E. PICHT, ANDREW ROBBINS, NATALIE R. SACKS, LAUREN SILVERNAIL, LAUREN P. SILVERNAIL, JOANNE VINEY, LUKE WALKER, LUKE NATHANIEL WALKER, HOLGER WESCHE
DIRECTOR
AURA BIOSCIENCES, INC.
JOSE BASELGA, PH.D., JOSE- BASELGA, PH.D., LAWRENCE C. BEST, CASPER BREUM, ELISABET DE LOS PINOS, PH.D., JULIE FEDER, PETER FINN, PETER B. FINN, JAVIER GARCIA, SALVADOR GARCIA-ATANCE, LEWIS GEFFEN, GEORGE GOLUMBESKI, PH.D., PEDRO GRANADILLO, JOEL JEAN-MAIRET, PH.D., DAVID JOHNSON, SEBASTIAN JULIA, GIOVANNI MARIGGI, PH.D., EDMUNDO MUNIZ, M.D., PH.D., ART PAPPAS, RAJ PAREKH, PH.D., DALE PFOST, PH.D., ISRAEL RUIZ, CHRISTIAN SCHETTER, KARAN TAKHAR, HENRI TERMEER, ALAN WALTS, ALAN WALTS, PH.D., ALAN E. WALTS, PH.D., PETER WIRTH, MICHAEL WYZGA
DIRECTOR
VELOSBIO INC.
ALAN COLOWICK, MIN CUI, CAM GALLAGHER, SCOTT L. GLENN, DAVID JOHNSON, SCOTT KARCHMER, CLAYTON KNOX, LANGDON MILLER, JAYSON PUNWANI, KARAN TAKHAR, JONATHAN TOBIN, RICHARD VINCENT
DIRECTOR
IMARA INC.
CHRISTOPH M. ADAMS, METTE KIRSTINE AGGER, RAHUL BALLAL, JAKE BAUER, DAVID BONITA, HELEN COLLINS, BARBARA DALTON, MIKA DERYNCK, CARL GOLDFISCHER, RISHI GUPTA, RICHARD HEYMAN, BENJAMIN HOHL, ROBERT HOPFNER, SAMUEL KINTZ, JOSEPH P. LYSSIKATOS, JAMES G. MCARTHUR, DAVID MOTT, SARA NAYEEM, ANISH PATEL, ANDREW PHILLIPS
DIRECTOR
ITERUM THERAPEUTICS BERMUDA LTD
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, PATRICK J. HERON, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS PLC
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, MICHAEL W. DUNNE, PAUL R. EDICK, COREY N. FISHMAN, JAMES I. HEALY, PATRICK HERON, PATRICK J. HERON, ROBERT HOPFNER, RONALD M. HUNT, DAVID KELLY, DAVID I. KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS, TRACY SAXTON, JEFF SCHAFFNIT
DIRECTOR
ITERUM THERAPEUTICS US LTD
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, PATRICK J. HERON, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS US HOLDING LTD
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, PATRICK J. HERON, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS INTERNATIONAL LTD
BRENTON K. AHRENS, LOUISE BARRETT, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, PATRICK J. HERON, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
SORRISO PHARMACEUTICALS, INC.
BRIAN DORSEY, SUSAN DUBE, MICHAEL GREY, CIARA KENNEDY, PH.D., EDWARD MATHERS
DIRECTOR
ENSOMA, INC.
KOUKI HARASAKI, STEPHEN KNIGHT, EMILE NUWAYSIR, KUSH PARMAR, KUSH M PARMAR, ALBERT SEYMOUR, NIHAL SINHA, PAULA SOTEROPOULOS
DIRECTOR
AVENZOAR PHARMACEUTICALS, INC.
TERRANCE BRUGGEMAN, TERRANCE J. BRUGGEMAN, MOUAD EDDERKAOUI, DAVID KRAMER, STEPHEN PANDOL, WILLIAM REAVEY, SHIERLEY WIDJAJA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2023-10-25 
2023-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-05-31 
2023-05-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-23 
2023-04-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
Equity 
2023-03-23 
2023-01-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-23 
2022-01-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-21 
2020-07-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-07-02 
2020-06-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-06-05 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2019-06-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-25 
2019-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2019-03-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-15 
2018-12-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-20 
2018-11-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-10-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-28 
2018-07-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-30 
2018-06-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-25 
2018-03-02
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
2018-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-20 
2017-08-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-30 
2017-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-24 
2017-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
2016-08-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-30